However, when mice are supplemented with liquid sucrose—a dietary intervention that increases de novo lipogenesis (DNL), liver-specific Agpat5 deletion significantly improves hyperinsulinemia and glucose intolerance. The gene discussed is AGPAT5; the disease is hyperinsulinism.